Marketwatch Up 80% in 6 months, this stock may still have 5% more upside Admin September 18, 2020 The company announced post market hours Thursday that it had settled a patent suit in the US for sale of a generic version cancer drug in that market. The short-term range for the stock is 4,546-5,054. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
